Free Trial

Thames Ventures VCT 2 Healthcare Shs (TV2H) Competitors

GBX 37.50 +1.00 (+2.74%)
(As of 11/14/2024)

TV2H vs. SDV, ALAI, OFG, CBA, JRS, ALM, GPM, HDIV, VNC, and GV2O

Should you be buying Thames Ventures VCT 2 Healthcare Shs stock or one of its competitors? The main competitors of Thames Ventures VCT 2 Healthcare Shs include Chelverton UK Dividend Trust (SDV), abrdn Latin American Income Fund (ALAI), Octopus Future Generations VCT (OFG), Ceiba Investments (CBA), JPMorgan Russian Securities (JRS), Allied Minds (ALM), Golden Prospect Precious Metal (GPM), Henderson Diversified Income (HDIV), Ventus VCT 2 C (VNC), and Gresham House Renewable Energy VCT 2 (GV2O). These companies are all part of the "asset management" industry.

Thames Ventures VCT 2 Healthcare Shs vs.

Thames Ventures VCT 2 Healthcare Shs (LON:TV2H) and Chelverton UK Dividend Trust (LON:SDV) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership.

Thames Ventures VCT 2 Healthcare Shs has a net margin of 0.00% compared to Chelverton UK Dividend Trust's net margin of -0.25%. Thames Ventures VCT 2 Healthcare Shs' return on equity of 0.00% beat Chelverton UK Dividend Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Thames Ventures VCT 2 Healthcare ShsN/A N/A N/A
Chelverton UK Dividend Trust -0.25%-0.01%0.90%

In the previous week, Thames Ventures VCT 2 Healthcare Shs' average media sentiment score of 0.00 equaled Chelverton UK Dividend Trust'saverage media sentiment score.

Company Overall Sentiment
Thames Ventures VCT 2 Healthcare Shs Neutral
Chelverton UK Dividend Trust Neutral

Thames Ventures VCT 2 Healthcare Shs has higher earnings, but lower revenue than Chelverton UK Dividend Trust.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thames Ventures VCT 2 Healthcare ShsN/AN/AN/A-£0.02-1,875.00
Chelverton UK Dividend Trust£1.63M21.59-£2.60MN/AN/A

Chelverton UK Dividend Trust received 62 more outperform votes than Thames Ventures VCT 2 Healthcare Shs when rated by MarketBeat users.

CompanyUnderperformOutperform
Thames Ventures VCT 2 Healthcare ShsN/AN/A
Chelverton UK Dividend TrustOutperform Votes
62
54.39%
Underperform Votes
52
45.61%

Thames Ventures VCT 2 Healthcare Shs pays an annual dividend of GBX 1 per share and has a dividend yield of 2.7%. Chelverton UK Dividend Trust pays an annual dividend of GBX 13 per share and has a dividend yield of 8.1%. Thames Ventures VCT 2 Healthcare Shs pays out -5,000.0% of its earnings in the form of a dividend.

5.7% of Chelverton UK Dividend Trust shares are held by institutional investors. 0.1% of Thames Ventures VCT 2 Healthcare Shs shares are held by company insiders. Comparatively, 36.9% of Chelverton UK Dividend Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Chelverton UK Dividend Trust beats Thames Ventures VCT 2 Healthcare Shs on 7 of the 10 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TV2H vs. The Competition

MetricThames Ventures VCT 2 Healthcare ShsAsset Management IndustryFinancial SectorLON Exchange
Market Cap£8.83M£961.43M£3.82B£1.85B
Dividend Yield2.29%5.67%4.37%6.26%
P/E Ratio-1,875.00769.39399.641,853.44
Price / SalesN/A3,806.552,525.35300,841.04
Price / CashN/A49.1143.6824.27
Price / BookN/A1.661.472.97
Net IncomeN/A£60.88M£461.39M£186.49M
7 Day PerformanceN/A0.65%1.18%-0.04%
1 Month PerformanceN/A0.65%2.01%-0.49%
1 Year PerformanceN/A11.26%15.66%26.36%

Thames Ventures VCT 2 Healthcare Shs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TV2H
Thames Ventures VCT 2 Healthcare Shs
N/AGBX 37.50
+2.7%
N/AN/A£8.83MN/A-1,875.00N/AGap Up
SDV
Chelverton UK Dividend Trust
N/AGBX 161.46
-1.5%
N/A+14.4%£35.20M£1.63M656.31N/A
ALAI
abrdn Latin American Income Fund
N/AGBX 60.25
flat
N/AN/A£34.41M£2.70M1,506.25N/A
OFG
Octopus Future Generations VCT
N/AGBX 82.50
flat
N/AN/A£33.93MN/A0.002,250High Trading Volume
CBA
Ceiba Investments
N/AGBX 24.50
flat
N/AN/A£33.73M£19.30M-612.50N/A
JRS
JPMorgan Russian Securities
N/AGBX 83
-0.4%
N/AN/A£33.56M£-259,516,000.0021.78N/A
ALM
Allied Minds
N/AGBX 13.85
+30.0%
N/AN/A£33.54M£2.86M-2.6631News Coverage
Gap Down
High Trading Volume
GPM
Golden Prospect Precious Metal
N/AGBX 39
+1.3%
N/A+57.0%£33.35MN/A-548.17N/ANews Coverage
HDIV
Henderson Diversified Income
N/AGBX 17.97
+0.1%
N/A-73.2%£32.72M£-30,190,000.00-449.25N/ADividend Cut
VNC
Ventus VCT 2 C
N/AGBX 86.50
+9,900.0%
N/AN/A£32.58M£9.47M4.08N/AGap Up
High Trading Volume
GV2O
Gresham House Renewable Energy VCT 2
N/AGBX 44.40
flat
N/AN/A£29.13MN/A0.00N/A

Related Companies and Tools


This page (LON:TV2H) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners